Cibus, Inc.
CBUSNasdaqMaterials · Agricultural Chemicals · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6M | $4.3M | $1.8M | $157,000 | $26.0M | $23.9M |
| Operating income | −$97.5M | −$258.4M | −$318.9M | −$22.4M | −$29.3M | −$43.8M |
| Net income | −$127.1M | −$251.4M | −$267.6M | −$16.9M | −$29.2M | −$44.8M |
| Total assets | $305.0M | $350.1M | $544.4M | $22.4M | $37.2M | $63.3M |
| Total liabilities | $283.2M | $252.2M | $206.1M | $15.2M | $23.1M | $26.5M |
| Equity | $21.8M | $92.2M | $293.5M | $7.2M | $14.1M | $36.9M |
| EPS (diluted) | $-2.78 | $-10.83 | $-25.95 | $-18.36 | $-0.78 | $-1.32 |
| Shares out. | 45.8M | 29.7M | 49.4M | 42.7M | 37.2M | 33.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −2680.1%
- Net margin
- −3492.3%
- Return on equity
- −582.2%
- Return on assets
- −41.7%
- Return on capital (ROCE)
- −33.8%
- Liabilities / assets
- 92.8%
- Debt / equity
- 12.97×
- Book value / share
- $0.48
- Revenue growth (YoY)
- −14.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -11.34distress
- Accruals / assets
- −25.1%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.6M | 16.5 | +5.1% |
| Apr 30, 2026 | 4.4M | 9.0 | +7.5% |
| Apr 15, 2026 | 4.1M | 5.3 | +19.8% |
| Mar 31, 2026 | 3.4M | 3.9 | +66.8% |
| Mar 13, 2026 | 2.1M | 5.0 | +1.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 14, 2026
- Director / officer changeApr 10, 2026
- Other material eventMar 27, 2026
- Results of operationsMar 17, 2026
- Other material eventJan 30, 2026
- Other material eventJan 28, 2026
- Other material eventJan 6, 2026
- Results of operationsNov 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTMay 22, 2026
- 424B3May 22, 2026
- 424B2May 22, 2026
- S-3May 15, 2026
- 10-QMay 14, 2026
- 8-KMay 14, 2026
- SCHEDULE 13G/AMay 6, 2026
- 4/APRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- 4PRIMARY DOCUMENTApr 28, 2026
- ARSApr 20, 2026